Cargando…
Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal tumors. However, the methodological differences between orthotopic and subcutaneous xenograft (OX and SX) models will cause confusion in understanding its pathological mechanism and clinical relevance. In this study, SX and OX models...
Autores principales: | Zhan, Bohan, Wen, Shi, Lu, Jie, Shen, Guiping, Lin, Xianchao, Feng, Jianghua, Huang, Heguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617422/ https://www.ncbi.nlm.nih.gov/pubmed/28977862 http://dx.doi.org/10.18632/oncotarget.18057 |
Ejemplares similares
-
Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling
por: Wen, Shi, et al.
Publicado: (2017) -
Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats
por: Wen, Shi, et al.
Publicado: (2016) -
Difference in morphology and interactome profiles between orthotopic and
subcutaneous gastric cancer xenograft models
por: Nakano, Kiyotaka, et al.
Publicado: (2018) -
The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts
por: Fung, Andrea S, et al.
Publicado: (2015) -
Different tumorigenicity and distinct metastasis and gene signature between orthotopic and subcutaneous neuroblastoma xenografted mice
por: Han, Rui, et al.
Publicado: (2022)